◎Main patent rights

 ・ Main Patent ①：『Assisting device for liquid drug permeation apparatus and liquid drug permeation system』

  This patent relates to a control method for appropriately applying a drug solution to the mucosal surface of a vesico-luminal organ under an endoscope, and is the basis of ETA™ (Endoscopic Topical Application™ ) therapy.

   ・USA（No. US20220111186A1）／Pending

   ・Japan（No. 6722965, scheduled to last until 2040/03/17）／Patented、European unitary patent（Germany, France, Italy etc.、17 countries）／Patented、England／Patented、Spain／Patented、Switzerland／Patented、China／Patented、Hong Kong／Patented、Macao／Patented、Taiwan／Patented

   ・India／Pending、Canada／Pending、Singapore／Pending、Australia／Pending、Israel／Pending

 ・ Main Patent ②：『Apparatus and system for controlling permeation and diffusion of solute and/or solvent locally』

  This is the base patent for Main Patent①.

   ・USA（No. US10272208B2, scheduled to last until 2035/12/11）／Patented

   ・Japan（No. 6418645, scheduled to last until 2035/04/09）／Patented

◎Registered trademark

・ USA :  AceMedic （No. 7198079）、 ETA （No. 7178304）

・ Europe :  AceMedic （No. 1655733）

・ Japan :  AceMedic （No. 6476059）、 ETA （No. 6476057）、 Endoscopic Topical Application （No. 6476058）

Rights regarding patent rights and registered trademarks (company name, services, products, etc.) posted on this website are owned by AceMedic Inc.. It belongs to the right holder whose use is licensed by AceMedic inc.. Violations such as unauthorized use are prohibited.